Article
Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
15 Oct 2020
Abstract excerpt
BACKGROUND: Immune checkpoint blockade (ICB) therapy has improved patient survival in a variety of cancers, but only a minority of cancer patients respond. Multiple studies have sought to identify general biomarkers of ICB response, but elucidating the molecular and cellular drivers of resistance for individual tumors remains challenging. We sought to determine whether a tumor with defined genetic background...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
